RETIFANLIMAB
UNII 2Y3T5IF01Z

Substance Identification & Data

This profile provides standardized clinical and technical data for Retifanlimab, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 2Y3T5IF01Z.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2079108-44-2 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

2Y3T5IF01Z

CAS Registry Number

2079108-44-2

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

RETIFANLIMAB

Official standardized name for this substance within the FDA UNII nomenclature system.

Molecular Formula

2Y3T5IF01Z

The specific atomic composition represented as a molecular structure string.

NCI Thesaurus

C142168

National Cancer Institute reference terminology for clinical and research data.

INN ID

11095

Sequential identifier assigned via the WHO International Nonproprietary Name program.

USAN ID

GH-96

Identifier assigned by the United States Adopted Names Council.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Retifanlimab. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

RETIFANLIMAB

RETIFANLIMAB-DLWR

Common Names & Synonyms

ANTI-PD-1 MONOCLONAL ANTIBODY MGA012

IMMUNOGLOBULIN G4, ANTI-(HUMAN PROGRAMMED CELL DEATH PROTEIN 1) (HUMANIZED MONOCLONAL MGA012 .GAMMA.4-CHAIN), DISULFIDE WITH HUMANIZED MONOCLONAL MGA012 .KAPPA.-CHAIN, DIMER

IMMUNOGLOBULIN G4-KAPPA, ANTI-(HOMO SAPIENS PROGRAMMED CELL DEATH PROTEIN 1 (PROTEIN PD-1CD279 ANTIGEN))MONOCLONAL ANTIBODY.GAMMA.4 HEAVY CHAIN HUMANIZED (1-445) (VH (HOMO SAPIENS IGHV1-46*01 (82%) (IGHD)-IGHJ4*01 (93%)) (8.8.12) (1-119)-HOMO SAPIENS IGHG4*01 (HINGE (S10>P(227)),CH3(K107>DEL(446))) (120-445)) (133-218')-DISULFIDE WITH .KAPPA. LIGHT CHAIN CHIMERIC (1'-218') (V-KAPPA (MUS MUSCULUS IGKV3-2*01 (81%) IGKJ2*01 (92%))/(HOMO SAPIENS IGKV3D-11*02 (78%) IGKJ4*01 (100%))(10.3.9) (1'-111')-HOMO SAPIENS IGKC*01 (112'-218')), DIMER (225-225'':228-228'')-BISDISULFIDE

RETIFANLIMAB [INN]

RETIFANLIMAB [USAN]

RETIFANLIMAB [WHO-DD]

RETIFANLIMAB DLWR [WHO-DD]